Cagrilintide is a long-acting amylin analogue that supports appetite regulation and weight optimization by activating amylin and calcitonin receptors. It enhances stability and efficacy, promoting satiety and reducing food intake. Clinical studies, especially in combination with semaglutide (CagriSema), show superior results in weight loss and glycemic control for obesity and type 2 diabetes.
Stay inspired, informed and connected.